Eosinophilic esophagitis epidemiology and demographics: Difference between revisions

	Eosinophilic Esophagitis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Eosinophilic Esophagitis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
X Ray
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Future or Investigational Therapies
Case Studies
Case #1
Eosinophilic esophagitis epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Eosinophilic esophagitis epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Eosinophilic esophagitis epidemiology and demographics
CDC on Eosinophilic esophagitis epidemiology and demographics
Eosinophilic esophagitis epidemiology and demographics in the news
Blogs on Eosinophilic esophagitis epidemiology and demographics
Directions to Hospitals Treating Eosinophilic esophagitis
Risk calculators and risk factors for Eosinophilic esophagitis epidemiology and demographics

Revision as of 02:09, 13 December 2017

The prevalence of EoE is approximately 50-100 per 100,000 individuals worldwide.

EoE is a rare disease that tends to affect people with a history of European ancestry.

@@ Line 10: / Line 10: @@
 ===Prevalence===
 *The prevalence of EoE is approximately 50-100 per 100,000 individuals worldwide.
-===Case-fatality rate/Mortality rate===
-*In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
-*The case-fatality rate/mortality rate of [disease name] is approximately [number range].
 ===Age===
@@ Line 19: / Line 15: @@
 ===Race===
-*There is no racial predilection to [disease name].
+*EoE usually affects individuals of the White race.
-*[Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].
 ===Gender===
 *Males are more commonly affected by EoE than females.